Feraccru is indicated in adults for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD). The medicine can only be obtained with a prescription.
For further information on Ferracru please click below:
- Feraccru European Public Assessment Report
- Feraccru Summary of Product Characteristics
- Feraccru Patient Information Leaflet
If you experience any side effects with Feraccru, talk to your doctor or nurse. This includes any side effects not listed in the patient information leaflet. You can also report side effects directly via the national reporting system: Yellow Card Scheme www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of Feraccru. Always read the patient information leaflet provided with your medicine.
If you have a question or complaint about our products, or have experienced a side effect, please contact us.